Napa’s Keto-Mojo Unveils a Breathalyzer That Reads Ketones Without a Fingerprick
The Napa company announced the device on Nov. 14, opened preorders at $249, and says limited production begins in January 2027. It measures acetone in a breath sample with ultraviolet light, instead of blood on a test strip.

NAPA: Keto-Mojo has built its business on a small blood sample. On Saturday, Nov. 14, the Napa metabolic health company unveiled a device that needs no blood at all: a breathalyzer that measures acetone in a user’s breath to show whether the body is producing ketones, the fuel made when it burns fat.
The company announced the Photoacoustic Breathalyzer at Hack Your Health 2026 and opened preorders the same day under the name Founders’ First Reserve. Keto-Mojo bills the unit as the world’s first photoacoustic breathalyzer, and its shop page prices it at $249, with a limit of one per order and the buyer charged at the time of preorder.

Light in, pressure out
The reading starts with ultraviolet light. Inside the device, a breath sample fills a small measurement chamber, and pulsed UV-C light is focused through a lens at the acetone molecules in that sample. The molecules absorb the light, release the energy as heat, and create tiny pressure waves. A sensitive sensor picks up those waves and converts them into an acetone reading, with stronger waves indicating more acetone in the breath.
The device reads acetone in a single breath sample. There is no blood, and there are no strips to buy.
The method is called photoacoustic spectroscopy, and the company traces its underlying principle to work Alexander Graham Bell first described in 1880. Because the measurement depends on how acetone absorbs light, rather than on a surface chemical reaction, Keto-Mojo says the sensing does not drift the way metal oxide breath sensors can, and the device uses no disposable sensors, strips or patches.
We’ve always believed that you can only improve what you measure,Dorian Greenow, founder and CEO of Keto-Mojo, in the company announcement of Nov. 14, 2026
The trade it is trying to end
The announcement frames the device against three older ways of checking ketosis. Blood testing, the method behind the company’s own GK+ meter, gives precise readings but requires a fingerprick and a continuing supply of test strips. Urine testing needs no blood but returns a general range rather than a precise level. Earlier breath monitors avoided blood as well, but the company says they have struggled with sensor degradation and interference from other gases.

On its product page, the company lists the Breathalyzer’s measurement range as 0 to 100 parts per million of breath acetone, its accuracy as plus or minus 1 part per million plus 10 percent of the reading, and its response time as an estimated 30 seconds. The page describes the unit as Swiss engineered and patent pending, and says it has minimal cross sensitivity to hydrogen and alcohol.
What a preorder buys
The box holds the device, a carrying pouch, two extra mouthpieces and a USB-C charging cable, and the unit carries a one year limited warranty against manufacturing defects. Readings sync by Bluetooth to the company’s MyMojoHealth app on iOS and Android, which the shop page says is needed to set the device up, after which testing can be done without a phone or an internet connection.
Keto-Mojo classifies the unit on its product page as a wellness product meant for tracking lifestyle patterns, and it says the device should not be used to diagnose, treat or monitor a medical condition. The company says limited production is expected to begin in January 2027, its shop page estimates shipping by January 2027, and orders are filled in the order they are received. A broader commercial launch is planned for 2027.
A Napa company built on a meter
Dorian Greenow and Gemma Kochis launched Keto-Mojo in 2017, according to the company’s own history, after their own experience with the ketogenic lifestyle. The company is best known for its GK+ Blood Glucose and Ketone Meter, which the announcement describes as FDA cleared, and for the MyMojoHealth platform that collects readings over time. The breathalyzer is presented as the next step in that same direction: more frequent measurement, with the results read against a person’s nutrition, fasting, exercise and daily habits.
What the announcement and the product page do not carry is independent test data setting the breath readings against blood readings. The accuracy figures published so far are the company’s own specifications, and the first production devices are still two months away, so the comparison that will decide how the unit is used has yet to be published.

None to date. The Tribune corrects errors promptly and transparently. Read our corrections policy.


